Vanguard Group’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$52.3M Buy
4,499,010
+521,352
+13% +$5.76M ﹤0.01% 2140
2025
Q3
$46.3M Sell
3,977,658
-347,887
-8% -$4.21M ﹤0.01% 2194
2025
Q2
$53.3M Buy
4,325,545
+678,994
+19% +$7.5M ﹤0.01% 2088
2025
Q1
$22.5M Buy
3,646,551
+268,360
+8% +$2.78M ﹤0.01% 2458
2024
Q4
$27.4M Buy
3,378,191
+309,514
+10% +$3.09M ﹤0.01% 2436
2024
Q3
$24.8M Buy
3,068,677
+166,147
+6% +$899K ﹤0.01% 2484
2024
Q2
$12.6M Sell
2,902,530
-25,656
-0.9% -$130K ﹤0.01% 2790
2024
Q1
$12.4M Buy
2,928,186
+102,851
+4% +$357K ﹤0.01% 2845
2023
Q4
$10.6M Buy
2,825,335
+174,587
+7% +$601K ﹤0.01% 2910
2023
Q3
$9.81M Buy
2,650,748
+97,451
+4% +$388K ﹤0.01% 2892
2023
Q2
$10.1M Buy
2,553,297
+615,536
+32% +$3.05M ﹤0.01% 2935
2023
Q1
$8.02M Buy
1,937,761
+140,435
+8% +$575K ﹤0.01% 3059
2022
Q4
$7.58M Buy
1,797,326
+820
+0% +$2.9K ﹤0.01% 3083
2022
Q3
$5.08M Buy
1,796,506
+141,500
+9% +$589K ﹤0.01% 3317
2022
Q2
$6.65M Sell
1,655,006
-159,269
-9% -$592K ﹤0.01% 3217
2022
Q1
$9.94M Sell
1,814,275
-6,725
-0.4% -$30.8K ﹤0.01% 3157
2021
Q4
$8.29M Buy
1,821,000
+10,054
+0.6% +$49.9K ﹤0.01% 3327
2021
Q3
$8.42M Buy
1,810,946
+70,820
+4% +$412K ﹤0.01% 3349
2021
Q2
$11.9M Buy
1,740,126
+157,536
+10% +$1.25M ﹤0.01% 3118
2021
Q1
$15.8M Buy
1,582,590
+228,962
+17% +$2.41M ﹤0.01% 2909
2020
Q4
$10.1M Buy
1,353,628
+62,974
+5% +$428K ﹤0.01% 2990
2020
Q3
$7.78M Buy
1,290,654
+72,581
+6% +$365K ﹤0.01% 2917
2020
Q2
$7.67M Buy
1,218,073
+21,830
+2% +$101K ﹤0.01% 2894
2020
Q1
$4.29M Buy
1,196,243
+73,075
+7% +$413K ﹤0.01% 3034
2019
Q4
$8.18M Buy
1,123,168
+1,702
+0.2% +$10.4K ﹤0.01% 2953
2019
Q3
$7.16M Buy
1,121,466
+88,984
+9% +$748K ﹤0.01% 2997
2019
Q2
$9.26M Buy
1,032,482
+111,060
+12% +$871K ﹤0.01% 2902
2019
Q1
$8.71M Buy
921,422
+93,678
+11% +$844K ﹤0.01% 2899
2018
Q4
$5.34M Buy
827,744
+293,121
+55% +$1.96M ﹤0.01% 3061
2018
Q3
$2.59M Buy
534,623
+177,379
+50% +$436K ﹤0.01% 3443
2018
Q2
$424K Sell
357,244
-3,577
-1% -$4.14K ﹤0.01% 3847
2018
Q1
$327K Buy
360,821
+21,720
+6% +$43.3K ﹤0.01% 3875
2017
Q4
$851K Buy
339,101
+101,290
+43% +$291K ﹤0.01% 3646
2017
Q3
$618K Sell
237,811
-3,968
-2% -$8.22K ﹤0.01% 3704
2017
Q2
$518K Buy
241,779
+7,030
+3% +$24K ﹤0.01% 3722
2017
Q1
$1.91M Buy
234,749
+4,141
+2% +$39.5K ﹤0.01% 3394
2016
Q4
$1.76M Sell
230,608
-25,465
-10% -$258K ﹤0.01% 3400
2016
Q3
$3.23M Buy
256,073
+33,559
+15% +$314K ﹤0.01% 3199
2016
Q2
$2.21M Buy
222,514
+1,504
+0.7% +$22.9K ﹤0.01% 3347
2016
Q1
$2.93M Buy
221,010
+1,536
+0.7% +$14.9K ﹤0.01% 3221
2015
Q4
$2.23M Buy
219,474
+4,231
+2% +$48.7K ﹤0.01% 3349
2015
Q3
$2.14M Buy
215,243
+68,159
+46% +$1.05M ﹤0.01% 3345
2015
Q2
$2.85M Buy
147,084
+38,186
+35% +$1.31M ﹤0.01% 3267
2015
Q1
$5.36M Buy
108,898
+41,803
+62% +$991K ﹤0.01% 2965
2014
Q4
$641K Hold
67,095
﹤0.01% 3656
2014
Q3
$631K Buy
67,095
+2,296
+4% +$21.9K ﹤0.01% 3647
2014
Q2
$586K Buy
64,799
+14,137
+28% +$121K ﹤0.01% 3635
2014
Q1
$636K Buy
+50,662
New +$595K ﹤0.01% 3591

Other funds holding CRMD